Intrust Bank NA Has $32.35 Million Position in HCA Healthcare, Inc. $HCA

Intrust Bank NA decreased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 3.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 69,298 shares of the company’s stock after selling 2,665 shares during the quarter. HCA Healthcare accounts for approximately 2.7% of Intrust Bank NA’s investment portfolio, making the stock its 9th largest position. Intrust Bank NA’s holdings in HCA Healthcare were worth $32,352,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of HCA. National Pension Service raised its stake in HCA Healthcare by 2.9% during the third quarter. National Pension Service now owns 626,585 shares of the company’s stock worth $267,051,000 after acquiring an additional 17,531 shares in the last quarter. Nordea Investment Management AB increased its position in HCA Healthcare by 11.2% during the 4th quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company’s stock worth $507,393,000 after purchasing an additional 108,849 shares in the last quarter. Savant Capital LLC increased its position in HCA Healthcare by 37.7% during the 3rd quarter. Savant Capital LLC now owns 4,548 shares of the company’s stock worth $1,938,000 after purchasing an additional 1,246 shares in the last quarter. Sector Gamma AS increased its position in HCA Healthcare by 36.0% during the 3rd quarter. Sector Gamma AS now owns 10,883 shares of the company’s stock worth $4,638,000 after purchasing an additional 2,883 shares in the last quarter. Finally, AlphaQuest LLC increased its position in HCA Healthcare by 2,855.2% during the 3rd quarter. AlphaQuest LLC now owns 5,999 shares of the company’s stock worth $2,557,000 after purchasing an additional 5,796 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on HCA shares. Leerink Partners lowered their price objective on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a research report on Monday, April 27th. UBS Group raised their price objective on shares of HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a report on Monday, February 23rd. Cantor Fitzgerald reiterated an “overweight” rating on shares of HCA Healthcare in a report on Wednesday, March 4th. Wall Street Zen lowered shares of HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Finally, Deutsche Bank Aktiengesellschaft dropped their price objective on shares of HCA Healthcare from $558.00 to $540.00 and set a “buy” rating for the company in a report on Tuesday, April 28th. Sixteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $515.77.

HCA Healthcare Stock Performance

NYSE:HCA opened at $403.98 on Wednesday. The company has a market capitalization of $89.62 billion, a PE ratio of 13.89, a P/E/G ratio of 1.34 and a beta of 1.18. The company has a 50 day simple moving average of $473.90 and a two-hundred day simple moving average of $485.20. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The firm had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same period in the prior year, the company posted $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Research analysts predict that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be issued a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is presently 10.73%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.